Immunovant (IMVT) Free Cash Flow (2019 - 2026)
Immunovant (IMVT) posted Free Cash Flow of -$95.0 million for Q1 2026, down 2.89% on a QoQ basis from -$92.3 million in Q4 2025, and up 19.37% year-over-year from -$79.6 million in Q1 2025.
Immunovant (IMVT) Free Cash Flow (2019 - 2026) Analysis & Trends
Immunovant's Free Cash Flow history runs 8 years deep, the most recent figure standing at -$95.0 million for Q1 2026.
- Quarterly Free Cash Flow rose 19.37% year-over-year to -$95.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$407.2 million (down 6.16% YoY) and the FY2026 annual result came in at -$407.2 million, down 6.16% from the prior year.
- Free Cash Flow was -$95.0 million for Q1 2026 at Immunovant, down from -$92.3 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$20.2 million in Q3 2022 and bottomed at -$117.8 million in Q1 2025.
- A 5-year average of -$72.2 million and a median of -$65.9 million in 2022 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow sank 210.2% — and 2023, when it rose 28.01%.
- Immunovant's Free Cash Flow stood at -$46.5 million in 2022, then declined by 1.3% to -$47.1 million in 2023, then slumped by 97.2% to -$92.9 million in 2024, then advanced by 0.6% to -$92.3 million in 2025, then decreased by 2.89% to -$95.0 million in 2026.
- Business Quant data shows IMVT's Free Cash Flow at -$95.0 million in Q1 2026, -$92.3 million in Q4 2025, and -$102.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Immunovant | 7.18 Bn | 7.18 Bn | - | -94.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94.99 Mn |
| Mar 31, 2026 | -94.99 Mn |
| Dec 31, 2025 | -92.33 Mn |
| Dec 31, 2025 | -92.33 Mn |
| Sep 30, 2025 | -102.52 Mn |
| Sep 30, 2025 | -102.52 Mn |
| Jun 30, 2025 | -117.41 Mn |
| Jun 30, 2025 | -117.41 Mn |
| Mar 31, 2025 | -117.82 Mn |
| Mar 31, 2025 | -117.82 Mn |
| Dec 31, 2024 | -92.88 Mn |
| Dec 31, 2024 | -92.88 Mn |
| Sep 30, 2024 | -96.54 Mn |
| Sep 30, 2024 | -96.54 Mn |
| Jun 30, 2024 | -76.38 Mn |
| Jun 30, 2024 | -76.38 Mn |
| Mar 31, 2024 | -60.06 Mn |
| Mar 31, 2024 | -60.06 Mn |
| Dec 31, 2023 | -47.10 Mn |
| Dec 31, 2023 | -47.10 Mn |